Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson&apos;s disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study

Parkinson’s Disease

Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: Relationship between the electrode trajectory and cognitive decline

Parkinsonism Relat Disord.

Tesio V, Rizzi L, Jiang T, Fronda C, Lanotte M, Castelli L

doi: 10.1016/j.parkreldis.

Anxiety and Depression

Anterior pallidal deep brain stimulation for Tourette's syndrome: a randomised, double-blind, controlled trial

Lancet Neurol.

Welter ML, Houeto JL, Thobois S, Bataille B, Guenot M, Worbe Y, Hartmann A, Czernecki V, Bardinet E, Yelnik J, du Montcel ST, Agid Y, Vidailhet M, Cornu P, Tanguy A, Ansquer S, Jaafari N, Poulet E, Serra G, Burbaud P, Cuny E, Aouizerate B, Pollak P, Chabardes S, Polosan M, Borg M, Fontaine D, Giordana B, Raoul S, Rouaud T, Sauvaget A, Jalenques I, Karachi C, Mallet L; STIC study group

doi: 10.1016/

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial

Lancet Neurol.

Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR, Henriksen T, van Laar T, Spivey K, Vel S, Staines H, Lees A

doi: 10.1016/S1474-

RECOMMENDED

Parkinson’s Disease

Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study

★ 1 Recommended by Prof. Dr Claudio Gobbi, Faculty Member

★ 3 Recommended by Prof. Dr Christian Kamm, Faculty Member

Lancet Neurol.

Olanow CW, Factor SA, Espay AJ, Hauser RA, Shill HA, Isaacson S, Pahwa R, Leinonen M, Bhargava P, Sciarappa K, Navia B, Blum D, CTH-300 Study investigators.

doi: 10.1016/S1474-4422(19)30396-5.

Parkinson’s Disease

Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis

JAMA Netw Open.

Artusi CA, Dwivedi AK, Romagnolo A, Pal G, Kauffman M, Mata I, Patel D, Vizcarra JA, Duker A, Marsili L, Cheeran B, Woo D, Contarino MF, Verhagen L, Lopiano L, Espay AJ, Fasano A, Merola A

doi: 10.1001/jamanetworkopen.

Further Publications Psychiatry

A randomised, double-blind, sham-controlled trial of deep brain stimulation of the bed nucleus of the stria terminalis for treatment-resistant obsessive-compulsive disorder

Transl Psychiatry

Mosley PE, Windels F, Morris J, Coyne T, Marsh R, Giorni A, Mohan A, Sachdev P, O'Leary E, Boschen M, Sah P, Silburn PA

doi: 10.1038/s41398-021-01307-9

Migraine and HeadacheMultiple Sclerosis

Safety and efficacy of dual-lead thalamic deep brain stimulation for patients with treatment-refractory multiple sclerosis tremor: a single-centre, randomised, single-blind, pilot trial

Lancet Neurol.

Oliveria SF, Rodriguez RL, Bowers D, Kantor D, Hilliard JD, Monari EH, Scott BM, Okun MS, Foote KD

doi: 10.1016/

Parkinson’s Disease

Medications, Deep Brain Stimulation, and Other Factors Influencing Impulse Control Disorders in Parkinson's Disease

Front Neurol.

Eisinger RS, Ramirez-Zamora A, Carbunaru S, Ptak B, Peng-Chen Z, Okun MS, Gunduz A

doi: 10.3389/fneur.2019.00086.

Subthalamic deep brain stimulation modulates conscious perception of sensory function in Parkinson's disease.

Pain.

Cury RG, Galhardoni R, Teixeira MJ, Dos Santos Ghilardi MG, Silva V, Myczkowski ML, Marcolin MA, Barbosa ER, Fonoff ET, Ciampi de Andrade D

Neurology · Psychiatry

Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study

Related content

Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: Relationship between the electrode trajectory and cognitive decline

Anterior pallidal deep brain stimulation for Tourette's syndrome: a randomised, double-blind, controlled trial

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial

Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study

Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis

A randomised, double-blind, sham-controlled trial of deep brain stimulation of the bed nucleus of the stria terminalis for treatment-resistant obsessive-compulsive disorder

Safety and efficacy of dual-lead thalamic deep brain stimulation for patients with treatment-refractory multiple sclerosis tremor: a single-centre, randomised, single-blind, pilot trial

Medications, Deep Brain Stimulation, and Other Factors Influencing Impulse Control Disorders in Parkinson's Disease

Subthalamic deep brain stimulation modulates conscious perception of sensory function in Parkinson's disease.